Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2): is it a marker for immunity?

Hassoba HM, Terrault NA, el-Gohary AM, Scheffel C, Jou C, Brackett J, Hunt J, Lou SC, Wright TL.

J Med Virol. 1997 Dec;53(4):354-60.

PMID:
9407383
2.
3.

Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody.

Tanaka T, Hess G, Schlueter V, Zdunek D, Tanaka S, Kohara M.

J Med Virol. 1999 Apr;57(4):370-5.

PMID:
10089049
4.

Antienvelope antibodies are protective against GBV-C reinfection: evidence from the liver transplant model.

Hassoba HM, Pessoa MG, Terrault NA, Lewis NJ, Hayden M, Hunt JC, Qiu X, Lou SC, Wright TL.

J Med Virol. 1998 Nov;56(3):253-8.

PMID:
9783694
5.

GB virus C/hepatitis G viremia and antibody response to the E2 protein of hepatitis G virus in hemodialysis patients.

Okuda M, Hino K, Korenaga M, Yamaguchi Y, Katoh Y, Mukaide M, Kaneda Y, Minaminozono T, Okita K.

J Clin Gastroenterol. 2000 Jun;30(4):425-8.

PMID:
10875473
6.

Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection.

Tillmann HL, Heringlake S, Trautwein C, Meissner D, Nashan B, Schlitt HJ, Kratochvil J, Hunt J, Qiu X, Lou SC, Pichlmayr R, Manns MP.

Hepatology. 1998 Aug;28(2):379-84.

PMID:
9696000
7.

Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.

Sheng L, Soumillion A, Peerlinck K, Verslype C, Schelstraete R, Gyselinck F, Emonds MP, Hess G, Vermylen J, Desmyter J, Yap SH.

Thromb Haemost. 1998 Apr;79(4):752-5.

PMID:
9569187
8.

GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.

Pawlotsky JM, Roudot-Thoraval F, Muerhoff AS, Pellerin M, Germanidis G, Desai SM, Bastie A, Darthuy F, Rémiré J, Zafrani ES, Soussy CJ, Mushahwar IK, Dhumeaux D.

J Med Virol. 1998 Jan;54(1):26-37.

PMID:
9443106
9.

Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre.

Desassis JF, Laperche S, Girault A, Kolko A, Bouchardeau F, Zins B, Poignet JL, Couroucé AM.

Nephrol Dial Transplant. 1999 Nov;14(11):2692-7.

PMID:
10534514
10.

Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alfa.

Enomoto M, Nishiguchi S, Fukuda K, Kuroki T, Tanaka M, Otani S, Ogami M, Monna T.

Hepatology. 1998 May;27(5):1388-93.

PMID:
9581696
11.

Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure.

Bourlet T, Guglielminotti C, Evrard M, Berthelot P, Grattard F, Frésard A, Lucht FR, Pozzetto B.

J Med Virol. 1999 Aug;58(4):373-7.

PMID:
10421404
12.

GBV-C/HGV infection in children with chronic hepatitis C.

Komatsu H, Fujisawa T, Inui A, Sogo T, Morinishi Y, Miyagawa Y, Inui M.

J Med Virol. 1999 Oct;59(2):154-9.

PMID:
10459149
13.
14.

Prevalence of GBV-C/HGV-RNA, virus genotypes, and anti-E2 antibodies in autoimmune hepatitis.

Tribl B, Schöniger-Hekele M, Petermann D, Bakos S, Penner E, Müller C.

Am J Gastroenterol. 1999 Nov;94(11):3336-40.

PMID:
10566740
15.

GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-alpha therapy.

Yu ML, Chuang WL, Dai CY, Chen SC, Lin ZY, Hsieh MY, Tsai JF, Wang LY, Chang WY.

Antiviral Res. 2001 Dec;52(3):241-9.

PMID:
11675141
16.

Molecular epidemiology of GB virus C/hepatitis G virus in Athens, Greece.

Anastassopoulou CG, Paraskevis D, Tassopoulos NC, Boletis J, Sypsa VA, Hess G, Hatzakis A.

J Med Virol. 2000 Jul;61(3):319-26.

PMID:
10861639
17.

Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis.

Hwang SJ, Lu RH, Chan CY, Chang FY, Lee SD.

J Med Virol. 1999 Jan;57(1):85-9.

PMID:
9890427
18.

HGV/GBV-C in liver tissue and in sera from patients with chronic hepatitis C.

Fabris P, Biasin MR, Infantolino D, Romanó L, Benedetti P, Tositti G, Pellizzer GP, Zanetti AR, Stecca C, Marchelle G, de Lalla F.

Infection. 1998 Sep-Oct;26(5):283-7.

PMID:
9795785
19.

GBV-C/HGV infection in end-stage renal disease: a serological and virological survey.

Fabrizi F, Lunghi G, Pozzi C, Colzani S, Tentori F, Del Vecchio L, Corti M, Pagano A, Locatelli F.

J Nephrol. 2000 Jan-Feb;13(1):68-74.

PMID:
10720218
20.

Profiles of GBV-C/hepatitis G virus markers in patients coinfected with hepatitis C virus.

Sauleda S, Reesink HJ, Esteban JI, Hess G, Esteban R, Guardia J.

J Med Virol. 1999 Sep;59(1):45-51.

PMID:
10440807

Supplemental Content

Support Center